Dr. Peter Vogt is a molecular biologist, virologist and geneticist. His research focuses on retroviruses and viral and cellular oncogenes.
Dr. Vogt received his undergraduate education in biology at the University of Würzburg and in 1959 was awarded his Ph.D. at the University of Tübingen for work done at the Max Planck Institute for Virology in Tübingen. From 1959 to 1962 he was Damon Runyon Cancer Research Fellow in the laboratory of Harry Rubin at the University of California in Berkeley and started to work on Rous sarcoma virus. He taught microbiology and molecular biology to medical and graduate students at the University of Colorado in Denver (1962-1967) and the University of Washington in Seattle (1967-1971). In 1971, he joined the University of Southern California as Hastings Professor of Microbiology and in 1980 assumed the chairmanship of the Department of Microbiology at the School of Medicine. Since 1993, he has been a Professor at The Scripps Research Institute in La Jolla. He served as the Executive Vice President and Chief Scientific Officer at Scripps from 2012 – 2015.
Dr. Vogt has received numerous awards, including the Irene Vogeler Prize (1976), the Alexander von Humboldt Award (1984), the Ernst Jung Prize for Medicine (1985), the Robert J. and Claire Pasarow Foundation Medical Research Award, the Paul Ehrlich and Ludwig Darmstaedter Prize (1988), the Bristol-Myers Squibb Award (1989), the Charles S. Mott Prize (1991), the Pezcoller Foundation-AACR International Award for Cancer Research (2013), the IHV Lifetime Achievement Award for Scientific Contributions (2016), the AICF Prize for Scientific Excellence in Medicine (2017), as well as NFCR’s Szent-Györgyi Prize for Progress in Cancer Research (2010).
Dr. Vogt holds an honorary doctorate from the University of Würzburg (since 1995) and has been elected to several academies, including the National Academy of Sciences USA, the American Philosophical Society, the American Academy of Arts and Sciences, the German National Academy of Sciences Leopoldina and the American Academy of Microbiology. He has served on several scientific advisory and editorial boards, such as the National Foundation for Cancer Research and the Proceedings of the National Academy of Sciences, USA (since 2000).